Truist Securities analyst Ravi Misra initiates coverage on Oranogenesis Holdings (NASDAQ: ORGO) with a Hold rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage